Kim Dong 4
4 · UroGen Pharma Ltd. · Filed Feb 2, 2023
Insider Transaction Report
Form 4
Kim Dong
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2023-01-31+10,000→ 10,000 total→ Ordinary Shares (10,000 underlying) - Award
Employee Stock Option (right to buy)
2023-01-31+38,000→ 38,000 totalExercise: $10.39Exp: 2033-01-31→ Ordinary Shares (38,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026.
- [F3]1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026.